BB Healthcare trust seeks to raise £200m in IPO

Sister for BB Biotech trust

Laura Dew
clock
BB Healthcare trust seeks to raise £200m in IPO

Bellevue Asset Management, manager of the BB Biotech trust, is to expand its range with the launch of a broader healthcare investment trust today.

Zurich-based Bellevue has $4bn invested in the healthcare industry and is seeking to raise £200m for the new trust. It will be a high conviction, long-only investment trust invested in listed or quoted...

To continue reading this article...

Join Investment week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

Trustpilot